PMID- 16268263
OWN - NLM
STAT- MEDLINE
DCOM- 20060127
LR  - 20181201
IS  - 0011-4162 (Print)
IS  - 0011-4162 (Linking)
VI  - 76
IP  - 3
DP  - 2005 Sep
TI  - Subacute cutaneous lupus erythematosus associated with leflunomide.
PG  - 189-92
AB  - A skin eruption consistent with subacute cutaneous lupus erythematosus (SCLE) 
      occurred in a patient taking leflunomide for rheumatoid arthritis. The eruption 
      resolved after discontinuation of the medication. Suppression of tumor necrosis 
      factor (TNF)-effector mechanisms by leflunomide may have played a role in the 
      pathogenesis of this disorder.
FAU - Elias, Anthony R
AU  - Elias AR
AD  - Dermatology Clinic, US Army Medical Department Activity, Fort Drum, New York 
      13602, USA. anthony.elias@us.army.mil
FAU - Tam, Christine C
AU  - Tam CC
FAU - David-Bajar, Kathleen M
AU  - David-Bajar KM
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Cutis
JT  - Cutis
JID - 0006440
RN  - 0 (Anti-Inflammatory Agents, Non-Steroidal)
RN  - 0 (Isoxazoles)
RN  - G162GK9U4W (Leflunomide)
SB  - IM
MH  - Anti-Inflammatory Agents, Non-Steroidal/*adverse effects
MH  - Arthritis, Rheumatoid/drug therapy
MH  - Female
MH  - Humans
MH  - Isoxazoles/*adverse effects
MH  - Leflunomide
MH  - Lupus Erythematosus, Cutaneous/*chemically induced
MH  - Middle Aged
EDAT- 2005/11/05 09:00
MHDA- 2006/01/28 09:00
CRDT- 2005/11/05 09:00
PHST- 2005/11/05 09:00 [pubmed]
PHST- 2006/01/28 09:00 [medline]
PHST- 2005/11/05 09:00 [entrez]
PST - ppublish
SO  - Cutis. 2005 Sep;76(3):189-92.